Trevor Hawkins

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study

David R. Nelson, James N. Cooper, Jacob Lalezari et al. · Hepatology · 2015 · 688 citations · Full text

Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients

Edwin DeJesus, Daniel Berger, Martin Markowitz et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 268 citations

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Sherene Min, Louis Sloan, Edwin DeJesus et al. · AIDS · 2011 · 212 citations

Intracellular Pharmacokinetics of Tenofovir Diphosphate, Carbovir Triphosphate, and Lamivudine Triphosphate in Patients Receiving Triple-Nucleoside Regimens

Trevor Hawkins, Wenoah Veikley, Robert L. St. Claire et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 198 citations

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Mark Sulkowski, Hugo E. Vargas, Adrian M. Di Bisceglie et al. · Gastroenterology · 2015 · 179 citations · Full text

Viral Hepatitis, Real-world Patients, Hcv Genotype 1 +10